India Buprenorphine Market Shipment Analysis
India Buprenorphine Market registered a decline of -2.72% in value shipments in 2022 as compared to 2021 and an increase of 4.59% CAGR in 2022 over a period of 2017. In Buprenorphine Market India is becoming less competitive as HHI index in 2022 was 5521 while in 2017 it was 4390. Herfindahl Index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means less numbers of players or countries exporting in the market. India has reportedly relied more on imports to meet its growing demand in Buprenorphine Market.
India is shifting towards local production to meet its demand as we see the trend is shifting towards reducing imports. The import factor of Buprenorphine Market in 2022 was 12.6 while in 2017 it was 16.41. France, Australia, Slovakia, Spain and USA were among the top players of the market in 2022, where France acquired the largest market share of 71.36% with a shipment value of 14.9 million USD in 2022 France also offered the product below the average market price thus having a competitive advantage over others In 2017 Australia had the largest market share of 46.82% with the shipment value of 7.68 million USD. The country was offering its product with an average price which is lower than the average market price offered in the country. As Australiaprice is lower than the average price, it provided a significant edge among other competitor in 2017.
